Ergoteles’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-279,056	Closed	-$405K	–	1528
2022 Q3	$405K	Sell	279,056 -38,944	-12%	-$56.5K	0.01%	841
2022 Q2	$582K	Buy	+318,000	New	+$582K	0.02%	773